AOBIOME Trademark

Trademark Overview


On Thursday, January 25, 2018, a trademark application was filed for AOBIOME with the United States Patent and Trademark Office. The USPTO has given the AOBIOME trademark a serial number of 87770621. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, April 11, 2022. This trademark is owned by AOBiome LLC. The AOBIOME trademark is filed in the Pharmaceutical Products and Medical Instrument Products categories with the following description:

Medicated gels for therapeutic use in the nature of therapeutic pharmaceuticals containing ammonia oxidizing bacteria for the treatment of inflammatory diseases, for the treatment of systemic diseases, namely, hypertension, other cardiovascular and circulatory disorders, and primary and secondary headache disorders including migraine, and to counteract skin damage caused by UV exposure or aging; medicated creams for therapeutic use in the nature of therapeutic pharmaceuticals containing ammonia oxidizing bacteria for the treatment of inflammatory diseases, for the treatment of systemic diseases, namely, hypertension, other cardiovascular and circulatory disorders, and primary and secondary headache disorders including migraine, and to counteract skin damage caused by UV exposure or aging; medicated sprays for therapeutic use in the nature of therapeutic pharmaceuticals containing ammonia oxidizing bacteria for the treatment of inflammatory diseases, for the treatment of systemic diseas...

Stents; intra-uterine contraceptive devices; catheters; pessaries; coatings sold as an integral component of medical stents and other implantable medical devices
aobiome

General Information


Serial Number87770621
Word MarkAOBIOME
Filing DateThursday, January 25, 2018
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, April 11, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 8, 2019

Trademark Statements


Goods and ServicesMedicated gels for therapeutic use in the nature of therapeutic pharmaceuticals containing ammonia oxidizing bacteria for the treatment of inflammatory diseases, for the treatment of systemic diseases, namely, hypertension, other cardiovascular and circulatory disorders, and primary and secondary headache disorders including migraine, and to counteract skin damage caused by UV exposure or aging; medicated creams for therapeutic use in the nature of therapeutic pharmaceuticals containing ammonia oxidizing bacteria for the treatment of inflammatory diseases, for the treatment of systemic diseases, namely, hypertension, other cardiovascular and circulatory disorders, and primary and secondary headache disorders including migraine, and to counteract skin damage caused by UV exposure or aging; medicated sprays for therapeutic use in the nature of therapeutic pharmaceuticals containing ammonia oxidizing bacteria for the treatment of inflammatory diseases, for the treatment of systemic diseases, namely, hypertension, other cardiovascular and circulatory disorders, and primary and secondary headache disorders including migraine, and to counteract skin damage caused by UV exposure or aging; nasal sprays for therapeutic use; topical applications in the nature of gels, creams, sprays, and liquids for therapeutic use, namely, topical preparations containing ammonia oxidizing bacteria for the treatment of skin disorders, acne, inflammation, eye disorders, migraines, headaches, allergic reactions, insomnia, hypertension, thermoregulation, and to promote wound healing; medicated liquids for therapeutic use in the nature of therapeutic pharmaceuticals for the treatment of inflammatory diseases, for the treatment of systemic diseases, namely, hypertension, other cardiovascular and circulatory disorders, and primary and secondary headache disorders including migraine, and to counteract skin damage caused by UV exposure or aging; biological therapeutics being pharmaceutical preparations for treatment of skin disorders, circulatory and cardiovascular disorders, neurologic diseases, inflammation, gastrointestinal disorders, respiratory disorders, eye disorders, urogenital disorders, auditory disorders, migraines, headaches, allergic rhinitis, insomnia, hyperhidrosis, acne, and hypertension; therapeutic agents for thermoregulation and promoting wound healing
Goods and ServicesStents; intra-uterine contraceptive devices; catheters; pessaries; coatings sold as an integral component of medical stents and other implantable medical devices

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, February 6, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateTuesday, February 6, 2018
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAOBiome LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressCambridge, MA 02140

Party NameAOBiome LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressCambridge, MA 02142

Trademark Events


Event DateEvent Description
Monday, April 11, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, April 11, 2022ABANDONMENT - NO USE STATEMENT FILED
Thursday, August 19, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 18, 2021EXTENSION 5 GRANTED
Monday, August 16, 2021EXTENSION 5 FILED
Wednesday, August 18, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, August 16, 2021TEAS EXTENSION RECEIVED
Thursday, February 11, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 9, 2021EXTENSION 4 GRANTED
Tuesday, February 9, 2021EXTENSION 4 FILED
Tuesday, February 9, 2021TEAS EXTENSION RECEIVED
Friday, September 4, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 2, 2020EXTENSION 3 GRANTED
Wednesday, September 2, 2020EXTENSION 3 FILED
Wednesday, September 2, 2020TEAS EXTENSION RECEIVED
Friday, March 6, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 4, 2020EXTENSION 2 GRANTED
Wednesday, March 4, 2020EXTENSION 2 FILED
Wednesday, March 4, 2020TEAS EXTENSION RECEIVED
Wednesday, July 24, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 22, 2019EXTENSION 1 GRANTED
Monday, July 22, 2019EXTENSION 1 FILED
Monday, July 22, 2019TEAS EXTENSION RECEIVED
Monday, July 22, 2019APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, July 22, 2019TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, March 5, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 8, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 8, 2019PUBLISHED FOR OPPOSITION
Wednesday, December 19, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 20, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, November 20, 2018EXAMINER'S AMENDMENT ENTERED
Tuesday, November 20, 2018NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, November 20, 2018EXAMINERS AMENDMENT E-MAILED
Tuesday, November 20, 2018EXAMINERS AMENDMENT -WRITTEN
Tuesday, November 13, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, November 13, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, November 13, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, May 15, 2018NOTIFICATION OF PRIORITY ACTION E-MAILED
Tuesday, May 15, 2018PRIORITY ACTION E-MAILED
Tuesday, May 15, 2018PRIORITY ACTION WRITTEN
Monday, May 7, 2018ASSIGNED TO EXAMINER
Tuesday, February 6, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, January 29, 2018NEW APPLICATION ENTERED IN TRAM